Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.

De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, Landry M, De Serres G.

JAMA. 2012 Jul 11;308(2):175-81. doi: 10.1001/jama.2012.7342.

PMID:
22782419
[PubMed - indexed for MEDLINE]
2.

Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.

Isai A, Durand J, Le Meur S, Hidalgo-Simon A, Kurz X.

Vaccine. 2012 Nov 19;30(49):7123-9. doi: 10.1016/j.vaccine.2012.09.032. Epub 2012 Sep 26. Review.

PMID:
23022149
[PubMed - indexed for MEDLINE]
3.

Guillain-Barré syndrome after exposure to influenza virus.

Lehmann HC, Hartung HP, Kieseier BC, Hughes RA.

Lancet Infect Dis. 2010 Sep;10(9):643-51. doi: 10.1016/S1473-3099(10)70140-7. Review.

PMID:
20797646
[PubMed - indexed for MEDLINE]
4.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
[PubMed - indexed for MEDLINE]
5.

[Guillain-Barré syndrome after exposure to influenza].

Hartung HP, Keller-Stanislawski B, Hughes RA, Lehmann HC.

Nervenarzt. 2012 Jun;83(6):714-30. doi: 10.1007/s00115-012-3479-8. Review. German.

PMID:
22528062
[PubMed - indexed for MEDLINE]
6.

Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature.

Cortese A, Baldanti F, Tavazzi E, Carnevale L, Minoli L, Lozza A, Marchioni E.

J Neurol Sci. 2012 Jan 15;312(1-2):173-6. doi: 10.1016/j.jns.2011.08.047. Epub 2011 Oct 13. Review.

PMID:
22000408
[PubMed - indexed for MEDLINE]
7.

[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].

Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL; le réseau français des centres de pharmacovigilance.

Therapie. 2011 Nov-Dec;66(6):527-40. doi: 10.2515/therapie/2011075. Epub 2011 Dec 21. Review. French.

PMID:
22186078
[PubMed - indexed for MEDLINE]
8.

Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.

Domingues CM, de Oliveira WK; Brazilian Pandemic Influenza Vaccination Evaluation Team.

Vaccine. 2012 Jul 6;30(32):4744-51. doi: 10.1016/j.vaccine.2012.05.007. Epub 2012 May 18. Review.

PMID:
22609010
[PubMed - indexed for MEDLINE]
9.

Safety review: squalene and thimerosal in vaccines.

Montana M, Verhaeghe P, Ducros C, Terme T, Vanelle P, Rathelot P.

Therapie. 2010 Nov-Dec;65(6):533-41. Epub 2010 Dec 23. Review.

PMID:
21176760
[PubMed - indexed for MEDLINE]
10.

Prevention of influenza in the general population.

Langley JM, Faughnan ME.

CMAJ. 2004 Nov 9;171(10):1213-22. Review.

PMID:
15534315
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Ethics of vaccination programs.

Schwartz JL, Caplan AL.

Curr Opin Virol. 2011 Oct;1(4):263-7. doi: 10.1016/j.coviro.2011.05.009. Epub 2011 Jun 16. Review.

PMID:
22440783
[PubMed - indexed for MEDLINE]
12.

Current experience with school-located influenza vaccination programs in the United States: a review of the medical literature.

Hull HF, Ambrose CS.

Hum Vaccin. 2011 Feb;7(2):153-60. Epub 2011 Feb 1. Review.

PMID:
21311217
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Influenza and pneumococcal disease in the community.

Riley C, Riley S.

Nurs Stand. 2003 Oct 8-14;18(4):45-51; quiz 52, 55. Review.

PMID:
14601214
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk